GVM’s Department of Arrhythmology and Electrophysiology is a international reference centre in the treatment of any type of heart rhythm disturbance and heart failure and is equipped with the latest technologies, from robotic navigation, until the electric or hybrid reconstruction of the heart chambers (with MRI, CT or rotational fluoroscopic reconstruction).
The Department it is a world leader in the treatment of atrial fibrillation by use of non-fluoroscopic electroanatomic mapping systems and reference center for treatment through the use of cryo-ballon and for pacemaker implants and defibrillators for the prevention of sudden death.
Are treated all cardiac arrhythmias, and in particular, the supraventricular tachycardia, Wolff-Parkinson-White (WPW) syndrome, ventricular tachycardia and arrhythmogenic genetic syndromes (right ventricular dysplasia, Brugada syndrome).
Is among the first in Europe to have used the of pacemaker implantation technique miniaturized (MICRA-TPS) for which the implantation technique is an international training center.
Among the first in Italy to use the TYRX system, fully resorbable antibacterial wrap can reduce by 90 percent the risk of bacterial infections - sometimes lethal - in patients implanted with pacemakers or removal/replacement. Is the new frontier of biomedicine in contrast to hospital infections in patients at high risk of infection.
In order to determine the quality and magnitude of the disorder, patients undergo an electrocardiogram, a Holter ECG and electrophysiological studies, in line with international guidelines. A cardiotelephone is also available for the detection and remote monitoring of symptoms.
4.405 patients were treated in 2014. In the Italian centres, 588 defibrillators and 751 pacemakers have been implanted, 1.929 ablations and studies have been performed and 538 otherwise classifiable cases of electrophysiology have been dealt with.